Blanco, Elvin
Houston Methodist,
United States
2025 Rank: 61669
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 349 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61669 | 71755 |
| Total Cites | 1019 | 1024 |
| H-index | 10 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 791 | 791 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 825 | 826 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 977 | 982 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.04 |
| Self-Citation Percentage |
0.49%
|
|
Blanco, Elvin
Weill Cornell Medicine,
United States
2024 Rank: 86517
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 508 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86517 | 94618 |
| Total Cites | 936 | 950 |
| H-index | 9 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 746 | 749 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 763 | 767 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 907 | 919 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.03 |
| Self-Citation Percentage |
1.47%
|
|
Blanco, Elvin
Weill Cornell Medicine,
United States
2023 Rank: 80317
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 515 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80317 | 88972 |
| Total Cites | 941 | 965 |
| H-index | 11 | 12 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 729 | 731 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 744 | 747 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 909 | 923 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.05 |
| Self-Citation Percentage |
2.49%
|
|
Blanco, Elvin
Houston Methodist,
United States
2022 Rank: 74140
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 469 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74140 | 86548 |
| Total Cites | 960 | 983 |
| H-index | 10 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 754 | 757 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 775 | 778 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 926 | 941 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.04 |
| Self-Citation Percentage |
2.34%
|
|
Blanco, Elvin
Houston Methodist,
United States
2021 Rank: 77666
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 497 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77666 | 87270 |
| Total Cites | 1508 | 1562 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 1172 | 1178 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 1196 | 1204 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1455 | 1488 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.05 |
| Self-Citation Percentage |
3.46%
|
|
Blanco, Elvin
Methodist Hospital Houston,
United States
2020 Rank: 64214
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 383 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64214 | 69228 |
| Total Cites | 1150 | 1205 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 905 | 915 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 919 | 929 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1096 | 1121 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.07 |
| Self-Citation Percentage |
4.56%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.